Shanghai Pharmaceuticals Holding News

Record table of Shanghai Pharma's investor relations activities in 202406

Jul 17 22:30 ET

Announcement from sh pharma on the consistency evaluation of generic bupivacaine hydrochloride injection.

Jul 17 12:00 ET

Announcement of the Resolution of the Twelfth Meeting of the Eighth Board of Directors of sh pharma Group Co., Ltd.

Jun 28 12:00 ET

Announcement Regarding the Consistent Evaluation of Dapantinib Tablets for Generic Drugs by SH Pharma Group Co., Ltd.

Jun 7 12:00 ET

Announcement of the resolution of the seventh meeting of the eighth session of the board of supervisors of SH Pharma Group Co., Ltd.

Jun 6 12:00 ET

Announcement of Resolutions of the 10th Meeting of the 8th Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.

May 30 12:00 ET

202405 Shanghai Pharmaceutical Investor Relations Activity Record Form - v2

May 30 05:29 ET

Announcement of Shanghai Pharmaceutical Group Co., Ltd. on holding a performance briefing for the first quarter of 2024

May 16 12:00 ET

Announcement of Shanghai Pharmaceutical Group Co., Ltd. on metoclopramide hydrochloride injection passing the generic drug consistency evaluation

May 16 12:00 ET

Announcement of Resolutions of the 9th Meeting of the 8th Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.

Apr 26 12:00 ET

20240409 Shanghai Pharmaceutical Investor Relations Activity Record Form - Hong Kong Roadshow

Apr 22 01:35 ET

Announcement of Shanghai Pharmaceutical Group Co., Ltd. on rabeprazole sodium enteric tablets passing the generic drug consistency evaluation

Apr 10 12:00 ET

Announcement of Shanghai Pharmaceutical Group Co., Ltd. on Lorazepam tablets passing the generic drug consistency evaluation

Apr 9 12:00 ET

20240329 Shanghai Pharmaceutical Investor Relations Activity Record Form (3)

Apr 8 02:35 ET

Shanghai Pharmaceutical Group Co., Ltd. 2023 Financial Statement and Audit Report - PwC Zhongtian Review (2024) No. 10006

Mar 28 12:00 ET

Feasibility analysis report of Shanghai Pharmaceutical Group Co., Ltd. on developing financial derivatives trading business

Mar 28 12:00 ET

Special Report on Capital Occupation by Controlling Shareholders and Other Related Parties of Shanghai Pharmaceutical Group Co., Ltd. - PricewaterhouseCoopers Zhongtian Special Review (2024) No. 1133

Mar 28 12:00 ET

Special opinion of the board of directors of Shanghai Pharmaceutical on the independence of the company's independent directors

Mar 28 12:00 ET

Shanghai Pharmaceutical Group Co., Ltd. 2023 Sustainability Report and Environmental, Social and Governance Report

Mar 28 12:00 ET

Shanghai Pharmaceutical Group Co., Ltd. 2023 Independent Director Debriefing Report-Gu Chaoyang

Mar 28 12:00 ET